DEA Seeks Public Input on Telemedicine and Remote Prescribing Regulations
The Drug Enforcement Administration (DEA) recently announced plans to host two public listening sessions on September 12 and 13, 2023. The purpose of these sessions is to gather further input on the practice of telemedicine, with an emphasis on the remote prescribing of controlled substances without an in-person evaluation of patients beforehand. The meetings will…